1. Home
  2. BWEN vs CTSO Comparison

BWEN vs CTSO Comparison

Compare BWEN & CTSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Broadwind Inc.

BWEN

Broadwind Inc.

HOLD

Current Price

$2.53

Market Cap

51.0M

Sector

Industrials

ML Signal

HOLD

Logo Cytosorbents Corporation

CTSO

Cytosorbents Corporation

HOLD

Current Price

$0.74

Market Cap

45.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BWEN
CTSO
Founded
N/A
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
51.0M
45.7M
IPO Year
2009
2008

Fundamental Metrics

Financial Performance
Metric
BWEN
CTSO
Price
$2.53
$0.74
Analyst Decision
Strong Buy
Buy
Analyst Count
1
2
Target Price
$6.00
$5.38
AVG Volume (30 Days)
243.5K
64.9K
Earning Date
05-11-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.27
N/A
Revenue
$146,785,000.00
$22,503,908.00
Revenue This Year
$11.75
$7.29
Revenue Next Year
N/A
$8.91
P/E Ratio
$9.17
N/A
Revenue Growth
N/A
48.53
52 Week Low
$1.41
$0.60
52 Week High
$4.15
$1.39

Technical Indicators

Market Signals
Indicator
BWEN
CTSO
Relative Strength Index (RSI) 44.13 65.19
Support Level $1.87 $0.61
Resistance Level $2.78 $1.02
Average True Range (ATR) 0.14 0.04
MACD 0.04 0.01
Stochastic Oscillator 57.32 91.86

Price Performance

Historical Comparison
BWEN
CTSO

About BWEN Broadwind Inc.

Broadwind Inc is a precision manufacturer of structures, equipment and components for clean technology and other specialized applications. The company provide technologically high value products to customers with complex systems and stringent quality standards that operate in energy, mining and infrastructure sectors, in the United States of America. It capabilities include heavy fabrications, welding, metal rolling, coatings, gear cutting and shaping, gearbox manufacturing and repair, heat treat, assembly, engineering and packaging solutions. It operates through four operating segments namely Heavy Fabrications, Gearing, Industrial Solutions and Corporate.

About CTSO Cytosorbents Corporation

CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.

Share on Social Networks: